ArticleCerebellum (London, England)2026
Hypothalamic Atrophy and Textural Changes in Polyglutamine Ataxias.
Article in Cerebellum (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Background. Spinocerebellar ataxia (SCA) presents a complex genetic landscape, with over 40 subtypes. These autosomal dominant disorders manifest late onset and severe disability, primarily impacting the cerebellum but also involving other nervous system structures. While a single study has linked hypothalamic atrophy to SCA3, further research is needed to confirm and/or expand this association. This study aimed to investigate hypothalamic involvement in PolyQ SCAs, focusing on SCA 1, 2, 3, and 6. Methods. We studied 135 adult patients with genetically confirmed SCA (SCA1, SCA2, SCA3, and SCA6) and 117 healthy controls. Hypothalamic subregions were segmented using H-SynEx, and both volumetric and texture features were extracted from MR images. Group differences were assessed with the Mann–Whitney U test, and associations with disease duration and severity (measured by SARA) were examined using Spearman’s rank correlation. Results. Significant atrophy of hypothalamic subregions was observed in SCA1, SCA3, and SCA6 when compared with controls, with the anterior subregion being affected in all cases. Texture analysis revealed widespread alterations in SCA1, SCA3, and SCA6 across all subregions. In SCA1 and SCA3, both volumetric and texture measures correlated with disease duration and SARA scores. These findings suggest that hypothalamic involvement in SCAs is complex and may occur before overt clinical manifestations. Key words: Ataxia, Polyglutamine disease, Hypothalamus, MRI, Volumetry
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.